Top

European Spine Journal

Published in:

01-01-2017 | Letter to the Editor

Letter to the Editor concerning “Surgical treatment of sacral chordoma: survival and prognostic factors” by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912–S917

Authors: Ming-Xiang Zou, Guo-Hua Lv, Xiao-Bin Wang, Jing Li

Published in: European Spine Journal | Issue 1/2017

Excerpt

Dear Editor, …

Ruosi C, Colella G, Di Donato SL, Granata F, Di Salvatore MG, Fazioli F (2015) Surgical treatment of sacral chordoma: survival and prognostic factors. Eur Spine J 24(Suppl 7):912–917CrossRefPubMed

Hayden JA, Côté P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144(6):427–437CrossRefPubMed

Bentzen SM (2001) Prognostic factor studies in oncology: osteosarcoma as a clinical example. Int J Radiat Oncol Biol Phys 49(2):513–518CrossRefPubMed

Kayani B, Sewell MD, Tan KA, Hanna SA, Williams R, Pollock R, Skinner J, Briggs TW (2015) Prognostic factors in the operative management of sacral chordomas. World Neurosurg 84(5):1354–1361CrossRefPubMed

Kayani B, Hanna SA, Sewell MD, Saifuddin A, Molloy S, Briggs TW (2014) A review of the surgical management of sacral chordoma. Eur J Surg Oncol 40(11):1412–1420CrossRefPubMed

Smith DL, Soria JC, Morat L, Yang Q, Sabatier L, Liu DD, Nemr RA, Rashid A, Vauthey JN (2004) Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11:45–51CrossRefPubMed

González-Sistal A, Sánchez AB, Del Rio MC, Arias JI, Herranz M, Ruibal A (2014) Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program. Anticancer Res 34(1):269–273PubMed

Zou MX, Lv GH, Li J, She XL, Jiang Y (2016) Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis. Am J Transl Res 8(2):516–529PubMedPubMedCentral

von Witzleben A, Goerttler LT, Lennerz J, Weissinger S, Kornmann M, Mayer-Steinacker R, von Baer A, Schultheiss M, Möller P, Barth TF (2015) In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival. Eur Spine J. doi:10.1007/s00586-015-4242-1

10.

Angelini A, Pala E, Calabrò T, Maraldi M, Ruggieri P (2015) Prognostic factors in surgical resection of sacral chordoma. J Surg Oncol 112:344–351CrossRefPubMed

11.

Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A, Picci P (2010) Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 17:211–219CrossRefPubMed

12.

Varga PP, Szövérfi Z, Fisher CG, Boriani S, Gokaslan ZL, Dekutoski MB, Chou D, Quraishi NA, Reynolds JJ, Luzzati A, Williams R, Fehlings MG, Germscheid NM, Lazary A, Rhines LD (2015) Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Eur Spine J 24:1092–1101CrossRefPubMed

13.

Radaelli S, Stacchiotti S, Ruggieri P, Donati D, Casali PG, Palmerini E, Collini P, Gambarotti M, Porcu L, Boriani S, Gronchi A, Picci P (2016) Sacral chordoma: long-term outcome of a large series of patients surgically treated at two reference centers. Spine (Phila Pa 1976) 41:1049–1057CrossRef

14.

Zou MX, Huang W, Wang XB, Li J, Lv GH, Wang B, Deng YW (2015) Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients. Eur Spine J 24:1738–1746CrossRefPubMed

15.

Chen H, Zhang K, Wu G, Song D, Chen K, Yang H (2015) Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis. Int J Clin Exp Pathol 8:14741–14748PubMedPubMedCentral

16.

Zou MX, Huang W, Wang XB, Lv GH, Li J, Deng YW (2014) Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma. Int J Clin Exp Pathol 7:4877–4885PubMedPubMedCentral

Title: Letter to the Editor concerning “Surgical treatment of sacral chordoma: survival and prognostic factors” by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912–S917
Authors: Ming-Xiang Zou
Guo-Hua Lv
Xiao-Bin Wang
Jing Li
Publication date: 01-01-2017
Publisher: Springer Berlin Heidelberg
Published in: European Spine Journal / Issue 1/2017
Print ISSN: 0940-6719
Electronic ISSN: 1432-0932
DOI: https://doi.org/10.1007/s00586-016-4819-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Letter to the Editor concerning “Surgical treatment of sacral chordoma: survival and prognostic factors” by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912–S917

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Reducing kyphotic deformity by posterior vertebral column resection with 360° osteosynthesis in metastatic epidural spinal cord compression (MESCC)

Effect of pure muscle retraction on multifidus injury and atrophy after posterior lumbar spine surgery with 24 weeks observation in a rabbit model

Spinal cord injury: a review of the most-cited publications

The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the “medical” articles in the European Spine Journal, 2016

Single vs two attending senior surgeons: assessment of intra-operative blood loss at different surgical stages of posterior spinal fusion surgery in Lenke 1 and 2 adolescent idiopathic scoliosis

In vitro evaluation of translating and rotating plates using a robot testing system under follower load